Umesh T. Sankpal - Concepedia

Author

Umesh T. Sankpal

Also Known As

Sankpal, Umesh, Sankpal, Umesh T, Sankpal, Umesh T, PhD, Sankpal, Umesh T., Sankpal, Umesh, PhD, U T Sankpal, U. Sankpal, U. T. Sankpal, U.T. Sankpal, UT Sankpal

107

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Texas College University of North Texas Health Science Center University of North Texas Orlando Health The University of Texas MD Anderson Cancer Center

About

Umesh T. Sankpal is an author at Texas College specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	913
2	Cell Biology	8	8	612
3	Natural Sciences	5	5	617
4	Biochemistry	4	4	67
5	Chemical Biology	2	2	41

Umesh T. Sankpal

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
DNA Methylation Inhibitor 5-Aza-2′-Deoxycytidine Induces Reversible Genome-Wide DNA Damage That Is Distinctly Influenced by DNA Methyltransferases 1 and 3B Stela S. Palii, Beth O. Van Emburgh, Umesh T. Sankpal, Molecular and Cellular Biology Histone ModificationsDna DamageEpigenetic ChangeGeneticsDna Methylation	2007	377
Role of KCNMA1gene in breast cancer invasion and metastasis to brain Divya Khaitan, Umesh T. Sankpal, Babette B. Weksler, BMC Cancer	2009	132
DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation system Theresa M. Geiman, Umesh T. Sankpal, Andrea K. Robertson, Biochemical and Biophysical Research Communications Histone ModificationsHdacs 1Histone Methylation SystemGeneticsDna Methylation	2004	123
Effects of chromatin structure on the enzymatic and DNA binding functions of DNA methyltransferases DNMT1 and Dnmt3a in vitro Andrea K. Robertson, Theresa M. Geiman, Umesh T. Sankpal, Biochemical and Biophysical Research Communications Histone ModificationsChromatinChromatin StructureChromatin RemodelingNatural Sciences	2004	76
Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors Riyaz Basha, Susan B. Ingersoll, Umesh T. Sankpal, Gynecologic Oncology Oncogenic AgentMedicinePharmacologyCancer Cell BiologyTumor Suppressor	2011	58
Combination of Tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species Umesh T. Sankpal, Ganji Purnachandra Nagaraju, Sriharika Gottipolu, Oncotarget Chemoprevention StrategyTolfenamic AcidSpecific Transcription FactorsCrc CellsReactive Oxygen Species	2015	57
Small molecule tolfenamic acid inhibits PC‐3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer Umesh T. Sankpal, Maen Abdelrahim, Sarah F. Connelly, The Prostate	2012	47
Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution Riyaz Basha, Sarah F. Connelly, Umesh T. Sankpal, The Journal of Nutritional Biochemistry Cycle Phase DistributionPancreatic CancerMedicinePharmacologyNf-kb Translocation	2016	47
Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: A novel therapeutic agent for neuroblastoma Don Eslin, Umesh T. Sankpal, Chris Lee, Molecular Carcinogenesis	2011	34
Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation Umesh T. Sankpal, Susan B. Ingersoll, Sarfraz Ahmad, Tumor Biology	2016	31

Page 1